Publicaciones en las que colabora con ANA ISABEL SÁNCHEZ FRUCTUOSO (12)

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

2020

  1. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2013

  1. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

2009

  1. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2309-2312

2007

  1. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159

2006

  1. Diagnóstico de la NCT

    Nefrologia, Vol. 26, Núm. SUPPL.1, pp. 15-16

  2. Factores de riesgo asociados a la NCT

    Nefrologia, Vol. 26, Núm. SUPPL.1, pp. 7-14

  3. Impacto de la Nefropatía Crónica del Trasplante (NCT) en la evolución del trasplante

    Nefrologia, Vol. 26, Núm. SUPPL.1, pp. 4-6

  4. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

    Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658

  5. Nefropatía crónica del trasplante (NCT).

    Nefrología : publicación oficial de la Sociedad Española Nefrologia., Vol. 26 Suppl 1, pp. 1-38

  6. Recomendaciones

    Nefrologia, Vol. 26, Núm. SUPPL.1, pp. 30-32

  7. Tratamiento y prevención de la NCT

    Nefrologia, Vol. 26, Núm. SUPPL.1, pp. 17-29